Tags

Type your tag names separated by a space and hit enter

Extracorporeal membrane oxygenation (ECMO) for neonatal respiratory failure.
Thorac Cardiovasc Surg. 1992 Dec; 40(6):316-22.TC

Abstract

Extracorporeal membrane oxygenation (ECMO) has been a successful treatment (82% survival) in over 5000 neonates with severe respiratory failure (80% predicted mortality without ECMO). ECMO is prolonged extracorporeal cardiopulmonary bypass achieved by extrathoracic vascular cannulation using a modified heart-lung machine. ECMO is currently the treatment of choice for full-term newborns with severe respiratory failure. The report summarizes indications, resulting complications, and future applications of neonatal ECMO.

Authors+Show Affiliations

Division of Cardiothoracic Surgery, University of Texas Medical Branch, Galveston.No affiliation info available

Pub Type(s)

Journal Article
Multicenter Study

Language

eng

PubMed ID

1290176

Citation

Zwischenberger, J B., and C S. Cox. "Extracorporeal Membrane Oxygenation (ECMO) for Neonatal Respiratory Failure." The Thoracic and Cardiovascular Surgeon, vol. 40, no. 6, 1992, pp. 316-22.
Zwischenberger JB, Cox CS. Extracorporeal membrane oxygenation (ECMO) for neonatal respiratory failure. Thorac Cardiovasc Surg. 1992;40(6):316-22.
Zwischenberger, J. B., & Cox, C. S. (1992). Extracorporeal membrane oxygenation (ECMO) for neonatal respiratory failure. The Thoracic and Cardiovascular Surgeon, 40(6), 316-22.
Zwischenberger JB, Cox CS. Extracorporeal Membrane Oxygenation (ECMO) for Neonatal Respiratory Failure. Thorac Cardiovasc Surg. 1992;40(6):316-22. PubMed PMID: 1290176.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Extracorporeal membrane oxygenation (ECMO) for neonatal respiratory failure. AU - Zwischenberger,J B, AU - Cox,C S,Jr PY - 1992/12/11/pubmed PY - 2001/3/28/medline PY - 1992/12/11/entrez SP - 316 EP - 22 JF - The Thoracic and cardiovascular surgeon JO - Thorac Cardiovasc Surg VL - 40 IS - 6 N2 - Extracorporeal membrane oxygenation (ECMO) has been a successful treatment (82% survival) in over 5000 neonates with severe respiratory failure (80% predicted mortality without ECMO). ECMO is prolonged extracorporeal cardiopulmonary bypass achieved by extrathoracic vascular cannulation using a modified heart-lung machine. ECMO is currently the treatment of choice for full-term newborns with severe respiratory failure. The report summarizes indications, resulting complications, and future applications of neonatal ECMO. SN - 0171-6425 UR - https://www.unboundmedicine.com/medline/citation/1290176/Extracorporeal_membrane_oxygenation__ECMO__for_neonatal_respiratory_failure_ L2 - https://www.thieme-connect.com/DOI/DOI?10.1055/s-2007-1020172 DB - PRIME DP - Unbound Medicine ER -